Exploring Patient Pain Experiences during and after Conventional Red Light and Simulated Daylight Photodynamic Therapy for Actinic Keratosis: A Qualitative Interview Study
DOI:
https://doi.org/10.2340/actadv.v104.19459Keywords:
interview, actinic keratosis, photodynamic therapy, person-centred care, qualitative research, painAbstract
Simulated daylight photodynamic therapy is a relatively new and potentially less painful alternative to conventional red light photodynamic therapy for actinic keratosis. Qualitative research exploring patient experiences of pain and skin reactions during these treatments is scarce. To address this, semi-structured interviews were conducted of 10 patients aged 60–81 years with symmetrically distributed actinic keratoses 4 weeks after split-face treatment with conventional red light photodynamic therapy and simulated daylight photodynamic therapy. The participants were recruited from an ongoing clinical randomized trial. Interviews (median length 35 min) were conducted between June 2022 and January 2023, audio-recorded, transcribed verbatim, and analysed qualitatively using content analysis, as described by Graneheim and Lundman. Participants reported that conventional red light photodynamic therapy was very painful during illumination and transiently painful in the post-treatment period, while simulated daylight photodynamic therapy was almost painless during illumination and led to minor post-treatment pain. Also, skin reactions were more intense and longer-lasting with conventional red light photodynamic therapy than with simulated daylight photodynamic therapy. Most participants expressed a treatment preference for simulated daylight photodynamic therapy but had reservations about its unestablished long-term effectiveness. This study underscores the considerable pain associated with conventional red light photodynamic therapy, and the pivotal importance of shared decision-making when selecting the most appropriate treatment.
Downloads
References
Morton CA, Szeimies RM, Basset-Seguin N, Calzavara-Pinton P, Gilaberte Y, Haedersdal M, et al. European Dermatology Forum guidelines on topical photodynamic therapy 2019 Part 1: treatment delivery and established indications - actinic keratoses, Bowen's disease and basal cell carcinomas. J Eur Acad Dermatol Venereol 2019; 33: 2225-2238.
https://doi.org/10.1111/jdv.16017 DOI: https://doi.org/10.1111/jdv.16017
Stangeland KZ, Kroon S. Cold air analgesia as pain reduction during photodynamic therapy of actinic keratoses. J Eur Acad Dermatol Venereol 2012; 26: 849-854.
https://doi.org/10.1111/j.1468-3083.2011.04167.x DOI: https://doi.org/10.1111/j.1468-3083.2011.04167.x
Halldin CB, Paoli J, Sandberg C, Gonzalez H, Wennberg AM. Nerve blocks enable adequate pain relief during topical photodynamic therapy of field cancerization on the forehead and scalp. Br J Dermatol 2009; 160: 795-800.
https://doi.org/10.1111/j.1365-2133.2008.09024.x DOI: https://doi.org/10.1111/j.1365-2133.2008.09024.x
Borelli C, Herzinger T, Merk K, Berking C, Kunte C, Plewig G, et al. Effect of subcutaneous infiltration anesthesia on pain in photodynamic therapy: a controlled open pilot trial. Dermatol Surg 2007; 33: 314-318. DOI: https://doi.org/10.1111/j.1524-4725.2007.33066.x
https://doi.org/10.1097/00042728-200703000-00009 DOI: https://doi.org/10.1097/00042728-200703000-00009
Wiegell SR, Haedersdal M, Wulf HC. Cold water and pauses in illumination reduces pain during photodynamic therapy: a randomized clinical study. Acta Derm Venereol 2009; 89: 145-149.
https://doi.org/10.2340/00015555-0568 DOI: https://doi.org/10.2340/00015555-0568
Wiegell SR, Wulf HC, Szeimies RM, Basset-Seguin N, Bissonnette R, Gerritsen MJ, et al. Daylight photodynamic therapy for actinic keratosis: an international consensus: International Society for Photodynamic Therapy in Dermatology. J Eur Acad Dermatol Venereol 2012; 26: 673-679.
https://doi.org/10.1111/j.1468-3083.2011.04386.x DOI: https://doi.org/10.1111/j.1468-3083.2011.04386.x
O'Mahoney P, Haigh N, Wood K, Brown CTA, Ibbotson S, Eadie E. A novel light source with tuneable uniformity of light distribution for artificial daylight photodynamic therapy. Photodiagnosis Photodyn Ther 2018; 23: 144-150.
https://doi.org/10.1016/j.pdpdt.2018.06.013 DOI: https://doi.org/10.1016/j.pdpdt.2018.06.013
O'Gorman SM, Clowry J, Manley M, McCavana J, Gray L, Kavanagh A, et al. Artificial white light vs daylight photodynamic therapy for actinic keratoses: a randomized clinical trial. JAMA Dermatol 2016; 152: 638-644.
https://doi.org/10.1001/jamadermatol.2015.5436 DOI: https://doi.org/10.1001/jamadermatol.2015.5436
Bai-Habelski JC, Medrano K, Palacio A, Reinhold U. No room for pain: a prospective study showing effective and nearly pain-free treatment of actinic keratosis with simulated daylight photodynamic therapy (SDL-PDT) using the IndoorLux® System in combination with BF-200 ALA (Ameluz®). Photodiagnosis Photodyn Ther 2022; 37: 102692.
https://doi.org/10.1016/j.pdpdt.2021.102692 DOI: https://doi.org/10.1016/j.pdpdt.2021.102692
Kellner C, Bauriedl S, Hollstein S, Reinhold U. Simulated-daylight photodynamic therapy with BF-200 aminolaevulinic acid for actinic keratosis: assessment of the efficacy and tolerability in a retrospective study. Br J Dermatol 2015; 172: 1146-1148.
https://doi.org/10.1111/bjd.13420 DOI: https://doi.org/10.1111/bjd.13420
Gerdes Medical AG. A new concept: simulated daylight PDT (SDL-PDT) with IndoorLux©. [cited 2023 December 12]. Available from: https://gerdesmedical.de/#concept.
Sjöholm A, Claeson M, Paoli J. Measurements of illuminance in simulated daylight photodynamic therapy. Photodermatol Photoimmunol Photomed 2022; 38: 564-570.
https://doi.org/10.1111/phpp.12792 DOI: https://doi.org/10.1111/phpp.12792
Arits AH, van de Weert MM, Nelemans PJ, Kelleners-Smeets NW. Pain during topical photodynamic therapy: uncomfortable and unpredictable. J Eur Acad Dermatol Venereol 2010; 24: 1452-1457.
https://doi.org/10.1111/j.1468-3083.2010.03670.x DOI: https://doi.org/10.1111/j.1468-3083.2010.03670.x
Sandberg C, Stenquist B, Rosdahl I, Ros AM, Synnerstad I, Karlsson M, et al. Important factors for pain during photodynamic therapy for actinic keratosis. Acta Derm Venereol 2006; 86: 404-408.
https://doi.org/10.2340/00015555-0098 DOI: https://doi.org/10.2340/00015555-0098
Gholam P, Denk K, Sehr T, Enk A, Hartmann M. Factors influencing pain intensity during topical photodynamic therapy of complete cosmetic units for actinic keratoses. J Am Acad Dermatol 2010; 63: 213-218.
https://doi.org/10.1016/j.jaad.2009.08.062 DOI: https://doi.org/10.1016/j.jaad.2009.08.062
Halldin CB, Gonzalez H, Wennberg AM, Lepp M. Patients' experiences of pain and pain relief during photodynamic therapy on actinic keratoses: an interview study. Acta Derm Venereol 2013; 93: 433-437.
https://doi.org/10.2340/00015555-1500 DOI: https://doi.org/10.2340/00015555-1500
Graneheim UH, Lundman B. Qualitative content analysis in nursing research: concepts, procedures and measures to achieve trustworthiness. Nurse Educ Today 2004; 24: 105-112.
https://doi.org/10.1016/j.nedt.2003.10.001 DOI: https://doi.org/10.1016/j.nedt.2003.10.001
Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care 2007; 19: 349-357.
https://doi.org/10.1093/intqhc/mzm042 DOI: https://doi.org/10.1093/intqhc/mzm042
Sandelowski M. Sample size in qualitative research. Res Nurs Health 1995; 18: 179-183.
https://doi.org/10.1002/nur.4770180211 DOI: https://doi.org/10.1002/nur.4770180211
Dresing TP, Thorsten/Schmieder, Christian Manual (on) Transcription. Transcription conventions, software guides and practical hints for qualitative researchers. 3rd English ed. online] 2015 [cited 2023 April 1]. Available from: https://www.audiotranskription.de/wp-content/uploads/2020/11/manual-on-transcription.pdf.
Lindgren BM, Lundman B, Graneheim UH. Abstraction and interpretation during the qualitative content analysis process. Int J Nurs Stud 2020; 108: 103632.
https://doi.org/10.1016/j.ijnurstu.2020.103632 DOI: https://doi.org/10.1016/j.ijnurstu.2020.103632
Shenton AK. Strategies for ensuring trustworthiness in qualitative research projects. Education for Information 2004; 22: 63-75.
https://doi.org/10.3233/EFI-2004-22201 DOI: https://doi.org/10.3233/EFI-2004-22201
Sandelowski M. Whatever happened to qualitative description? Res Nurs Health 2000; 23: 334-340.
https://doi.org/10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G DOI: https://doi.org/10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G
Halldin CB, Gillstedt M, Paoli J, Wennberg AM, Gonzalez H. Predictors of pain associated with photodynamic therapy: a retrospective study of 658 treatments. Acta Derm Venereol 2011; 91: 545-551.
https://doi.org/10.2340/00015555-1101 DOI: https://doi.org/10.2340/00015555-1101
Nguyen TN, Nilsson S, Hellström AL, Bengtson A. Music therapy to reduce pain and anxiety in children with cancer undergoing lumbar puncture: a randomized clinical trial. J Pediatr Oncol Nurs 2010; 27: 146-155.
https://doi.org/10.1177/1043454209355983 DOI: https://doi.org/10.1177/1043454209355983
Harvie SE. Aminolevulinic acid and photodynamic combination therapy in the treatment of actinic keratoses: caring for the patient. Dermatol Nurs 2007; 19: 31-39.
Kopasker D, Kwiatkowski A, Matin RN, Harwood CA, Ismail F, Lear JT, et al. Patient preferences for topical treatment of actinic keratoses: a discrete-choice experiment. Br J Dermatol 2019; 180: 902-909.
https://doi.org/10.1111/bjd.16801 DOI: https://doi.org/10.1111/bjd.16801
George CD, Tokez S, Hollestein L, Pardo LM, Keurentjes AJ, Wakkee M, et al. Longitudinal assessment of the prevalence of actinic keratosis and extensive risk factor evaluation: an update from the Rotterdam Study. J Invest Dermatol 2023; 143: 2193-2203.e12.
https://doi.org/10.1016/j.jid.2023.02.042 DOI: https://doi.org/10.1016/j.jid.2023.02.042
Lacour JP, Ulrich C, Gilaberte Y, Von Felbert V, Basset-Seguin N, Dreno B, et al. Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator-blinded, controlled, phase III study throughout Europe. J Eur Acad Dermatol Venereol 2015; 29: 2342-2348.
https://doi.org/10.1111/jdv.13228 DOI: https://doi.org/10.1111/jdv.13228
Reynolds KA, Schlessinger DI, Vasic J, Iyengar S, Qaseem Y, Behshad R, et al. Core outcome set for actinic keratosis clinical trials. JAMA Dermatol 2020; 156: 326-333.
https://doi.org/10.1001/jamadermatol.2019.4212 DOI: https://doi.org/10.1001/jamadermatol.2019.4212
Additional Files
Published
How to Cite
License
Copyright (c) 2024 Alexandra Sjöholm, Magdalena Claeson, John Paoli, Birgit Heckemann
This work is licensed under a Creative Commons Attribution 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
